Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3635114 | 0.84 | MAPT (0.65) | SIGMAR1MEN1KMT2AMAPTLMNA | |
| SCHEMBL2559529 | 0.83 | TDP1 (0.62) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL3256239 | 0.83 | DRD2 (0.52) | SIGMAR1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL24073901 | 0.81 | MAPT (0.57) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL16934915 | 0.79 | MAPT (0.59) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL17748966 | 0.79 | EPHX2 (0.61) | SIGMAR1MEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL901921 | 0.79 | NPY5R (0.57) | SIGMAR1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL17689749 | 0.79 | HTR1A (0.52) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL31398210 | 0.79 | MAPT (0.49) | MEN1KMT2AMAPTKDM4EPKM | |
| SCHEMBL23270984 | 0.78 | MEN1 (0.75) | MEN1KMT2AMAPTPKMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106622-A1 | Aryl-substituted alicylic compound and medical composition comprising the same | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106622-A1 | Aryl-substituted alicylic compound and medical composition comprising the same | ITGB3, ITGB1, ITGAL | SIGMAR1 1237/4885MEN1 4814/4885KMT2A 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.